Showing 3201-3210 of 6035 results for "".
- Tangible Science Launches Tangible Clean Multi-Purpose Solution for Tangible Hydra-PEG Coated Lenseshttps://modernod.com/news/tangible-science-launches-tangible-clean-multi-purpose-solution-for-tangible-hydra-peg-coated-lenses/2476412/Tangible Science launched a multi-purpose cleaning solution for Tangible Hydra-PEG coated lenses – Tangible Clean. The solution simplifies care for coated gas permeable (GP) lenses and can be used for cleaning, conditioning, disinfecting, protein removal, rinsing and storing them safely. Tangible
- Allergan Agrees to Split CEO, Chairman Roles at Next Leadership Transitionhttps://modernod.com/news/allergan-agrees-to-split-ceo-chairman-roles-at-next-leadership-transition/2476413/Allergan disclosed in a US Securities and Exchange Commission filing on Friday that it has agreed to split its chairman and chief executive roles, both currently held by CEO Brent Saunders, at the next leadership transition. The company said that splitting the roles now, as hedge fund Appaloosa h
- Study: Excess Hormones Could Cause a Condition That Can Lead to Blindness in Womenhttps://modernod.com/news/study-excess-hormones-could-cause-a-condition-that-can-lead-to-blindness-in-women/2476403/Research led by the University of Birmingham, UK, has found that increased levels of hormones including testosterone could cause a brain condition that can lead to blindness in women. Idiopathic Intracranial Hypertension—also known as IIH—is caused by high pressure in the brain with conseq
- Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kithttps://modernod.com/news/q-biomed-and-mannin-research-to-develop-gdf15-biomarker-glaucoma-diagnostic-kit/2476396/Q BioMed announced that its technology partner Mannin Research has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression. This enabling te
- Fluoride Can Cause Degenerative Eye Diseases, Study Showshttps://modernod.com/news/fluoride-can-cause-degenerative-eye-diseases-study-shows/2476388/Fluoride contributes to degenerative eye diseases such as cataracts, age related macular degeneration (AMD) and glaucoma, reports DT Waugh in the
- Acucela Signs Agreement to Develop a Compact OCT for NASA’s Deep Space Missionshttps://modernod.com/news/acucela-signs-agreement-to-develop-a-compact-oct-for-nasas-deep-space-missions/2476385/Acucela announced that the company signed the agreement with the Translational Research Institute for Space Health (TRISH) to develop a compact OCT device for NASA’s Deep Space missions. Approximately 63% of long-duration spaceflight crewmembers present with one or more signs of Spacefligh
- New Study Shows an Eye Scan Can Detect Signs of Alzheimer’s Diseasehttps://modernod.com/news/new-study-shows-an-eye-scan-can-detect-signs-of-alzheimers-disease/2476384/Researchers from the Duke Eye Center have shown that a new, noninvasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The researchers found that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer’s, and showed that the
- Study Demonstrates Long-Term IOP Reduction with the OMNI Surgical System Predicate Device (TRAB 360) in MIGShttps://modernod.com/news/clinical-study-demonstrates-long-term-iop-reduction-with-the-omni-surgical-system-predicate-device-trab-360-in-migs/2476378/A new, single-center retrospective study of glaucoma surgery patients published in the January 2019 issue of Clinical Ophthalmology shows that ab-interno trabeculotomy using one of Sight Sciences’ OMNI Surgical System’s Predicate Devices (TRAB 360)
- EyePoint Pharmaceuticals Announces US Commercial Launch of Dexycuhttps://modernod.com/news/eyepoint-pharmaceuticals-announces-us-commercial-launch-of-dexycu/2476370/EyePoint Pharmaceuticals announced that it has commercially launched Dexycu (dexamethasone intraocular suspension) 9% in the United States. Dexycu is the first and only FDA approved intraocular steroid for the treatment of postoperative inflammation and is administered as a single dose at the end
- Major League Soccer All-Star Alecko Eskandarian to Speak at Annual NORA Conferencehttps://modernod.com/news/major-league-soccer-all-star-alecko-eskandarian-to-speak-at-annual-nora-conference/2476364/Two-time Major League Soccer (MLS) All-Star Alecko Eskandarian will be the key-note speaker at the Neuro-Optometric Rehabilitation Association, International (NORA) 28th annual General Conference (September 21-22) at the Embassy Suites by Hilton Scottsdale Resorts, Scottsdale, Arizona.